...
首页> 外文期刊>Lipids in Health Disease >A high normal TSH level is associated with an atherogenic lipid profile in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease
【24h】

A high normal TSH level is associated with an atherogenic lipid profile in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease

机译:正常TSH水平高与新诊断为无症状冠心病的甲状腺功能正常的非吸烟者的动脉粥样硬化性脂质特征有关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Serum lipid profiles may be influenced by thyroid function, but the detailed mechanism remains unclear. Increasing evidence suggests that thyrotropin (TSH) may exert extra-thyroidal effects. The goal of this study was to evaluate the relationship between serum TSH levels and the lipid profiles in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease (CHD). Methods This was a retrospective study of 406 euthyroid non-smokers (187 males and 219 females) with newly diagnosed asymptomatic CHD from 2004 to 2010 in Jinan, China. Lipid parameters and the levels of TSH, FT3, and FT4 were determined. Multiple linear regression analysis and Logistic regression analysis were used to assess the influence of TSH on the lipid profiles and the risks of dyslipidemia. Results The TSH level, even within the normal range, was positively and linearly correlated with total cholesterol (TC), non-high density lipoprotein cholesterol (non-HDL-C) and triglycerides (TG) (Beta = 0.173, 0.181 and 0.103, respectively, P < 0.01 in all). With 1 mIU/L rise of TSH, the levels of TC, TG and non-HDL-C will increase by 1.010, 1.064, and 1.062 mmol/L, respectively. The odds ratio of hypercholesterolemia and hypertriglyceridemia with respect to the serum TSH level was 1.640 (95% CI 1.199-2.243, P = 0.002) and 1.349 (95% CI 1.054-1.726, P = 0.017), respectively. Conclusions TSH levels were correlated in a positive linear manner with the TC, non-HDL-C and TG levels in euthyroid non-smokers with newly diagnosed asymptomatic CHD. TSH in the upper limits of the reference range might exert adverse effects on lipid profiles and thus representing as a risk factor for hypercholesterolemia and hypertriglyceridemia in the context of CHD.
机译:背景血清脂质分布可能受甲状腺功能影响,但具体机制尚不清楚。越来越多的证据表明,促甲状腺激素(TSH)可能发挥甲状腺外作用。这项研究的目的是评估新诊断为无症状冠心病(CHD)的正常甲状腺非吸烟者的血清TSH水平与血脂谱之间的关系。方法这项回顾性研究于2004年至2010年在中国济南对406名新诊断为无症状冠心病的正常甲状腺不吸烟者(男187例,女219例)进行了回顾性研究。确定脂质参数和TSH,FT3和FT4的水平。使用多元线性回归分析和Logistic回归分析来评估TSH对血脂谱和血脂异常风险的影响。结果即使在正常范围内,TSH水平也与总胆固醇(TC),非高密度脂蛋白胆固醇(non-HDL-C)和甘油三酸酯(TG)呈线性正相关(β= 0.173、0.181和0.103,分别为P <0.01)。随着TSH升高1 mIU / L,TC,TG和非HDL-C的水平将分别增加1.010、1.064和1.062 mmol / L。高胆固醇血症和高甘油三酯血症相对于血清TSH水平的比值比分别为1.640(95%CI 1.199-2.243,P = 0.002)和1.349(95%CI 1.054-1.726,P = 0.017)。结论在新诊断为无症状冠心病的正常甲状腺非吸烟者中,TSH水平与TC,非HDL-C和TG水平呈线性正相关。在参考范围的上限内,TSH可能会对血脂状况产生不利影响,因此在冠心病的背景下,可作为高胆固醇血症和高甘油三酯血症的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号